Sign in
4

Changes in Ownership

KIORA PHARMACEUTICALS INC Filed Acc 0001372514-26-000007

Chief Development Officer gave up 238 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Daniels Eric Joseph · Chief Development Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-03 Shares withheld for taxes : show line 1 in the form −238 $2.02 $481 26,137 D
Loading xslF345X05/wk-form4_1772823830.xml…